Del Bufalo D - Search Results

1

miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.

De Luca T, Pelosi A, Trisciuoglio D, D'Aguanno S, Desideri M, Farini V, Di Martile M, Bellei B, Tupone MG, Candiloro A, Regazzo G, Rizzo MG, Del Bufalo D. De Luca T, et al. Among authors: del bufalo d, d aguanno s. Mol Carcinog. 2016 Dec;55(12):2304-2312. doi: 10.1002/mc.22437. Epub 2015 Nov 24. Mol Carcinog. 2016. PMID: 26599548

2

Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.

Zupi G, Molinari A, D'Agnano I, Meschini S, Del Bufalo D, Matarrese P, Candiloro A, Calcabrini A, Citro G, Arancia G. Zupi G, et al. Among authors: del bufalo d, d agnano i. Anticancer Res. 1995 Nov-Dec;15(6B):2469-77. Anticancer Res. 1995. PMID: 8669810

3

Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line.

Del Bufalo D, Biroccio A, Leonetti C, Zupi G. Del Bufalo D, et al. FASEB J. 1997 Oct;11(12):947-53. doi: 10.1096/fasebj.11.12.9337147. FASEB J. 1997. PMID: 9337147

4

bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells.

Biroccio A, Del Bufalo D, Fanciulli M, Bruno T, Zupi G, Floridi A. Biroccio A, et al. Among authors: del bufalo d. Int J Cancer. 1999 Jul 2;82(1):125-30. doi: 10.1002/(sici)1097-0215(19990702)82:1<125::aid-ijc21>3.0.co;2-q. Int J Cancer. 1999. PMID: 10360831

5

Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.

Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G. Leonetti C, et al. Among authors: del bufalo d. Clin Cancer Res. 1999 Sep;5(9):2588-95. Clin Cancer Res. 1999. PMID: 10499637

6

bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells.

Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A, Cippitelli M. Ricca A, et al. Among authors: del bufalo d. Int J Cancer. 2000 Apr 15;86(2):188-96. doi: 10.1002/(sici)1097-0215(20000415)86:2<188::aid-ijc7>3.0.co;2-w. Int J Cancer. 2000. PMID: 10738245

7

Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line.

Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G, Del Bufalo D. Biroccio A, et al. Among authors: del bufalo d. FASEB J. 2000 Apr;14(5):652-60. doi: 10.1096/fasebj.14.5.652. FASEB J. 2000. PMID: 10744622

8

c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.

Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G. Biroccio A, et al. Among authors: del bufalo d. Mol Pharmacol. 2001 Jul;60(1):174-82. doi: 10.1124/mol.60.1.174. Mol Pharmacol. 2001. PMID: 11408612

9

Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.

Del Bufalo D, Trisciuoglio D, Biroccio A, Marcocci L, Buglioni S, Candiloro A, Scarsella M, Leonetti C, Zupi G. Del Bufalo D, et al. J Cell Biochem. 2001 Aug 21-Sep 5;83(3):473-83. doi: 10.1002/jcb.1245. J Cell Biochem. 2001. PMID: 11596115

10

relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells.

Ricca A, Biroccio A, Trisciuoglio D, Cippitelli M, Zupi G, Del Bufalo D. Ricca A, et al. Among authors: del bufalo d. Br J Cancer. 2001 Dec 14;85(12):1914-21. doi: 10.1054/bjoc.2001.2174. Br J Cancer. 2001. PMID: 11747334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters